Human Cell Derived Off-The-Shelf Tissue Engineered Heart Valves for Next Generation TAVR: A Proof-of-Concept Study in Adult Sheep

First-in-Man Experience With a Large Bore (?14 FR) Bio-Resorbable Vascular Closure Device

Effect of a New Enhanced Fluoroscopy Technology (Valve ASSIST2) on Contrast and Radiation Use in Patients Undergoing TAVR

Featured Lecture: TAVR Innovation: Unresolved Clinical Issues and Opportunities For Further Technology Optimization

Case #4: TAVR for Pure Native Aortic Regurgitation - A Horrifying Ride

TAVR should be reserved for intermediate and higher-risk tricuspid valve aortic stenosis!

We’re ready to treat bicuspid valve and lower-risk tricuspid valve aortic stenosis!

TAVR Patient Journey V: Addressing Complications and Follow-up

TAVR Patient Journey IV: The Hospital Experience

TAVR Patient Journey III: Behind the Scenes